11/13/2008 News For: Financing Fo IvfSafeguard Scientifics And Oxford Bioscience Partners Co-Lead $12M Series A FINANCING FOR Molecular Biometrics Safeguard Scientifics, Inc., recently announced it co-led a $12M Series A financing round with Oxford Bioscience Partners for Molecular Biometrics, Inc. The metabolomics company's lead product, ViaMetrics-E, is a diagnostic procedure designed to help identify the most viable embryos with the greatest reproductive potential for in vitro fertilization IVF. IVF does not raise breast cancer risk London, Nov 12 : A new research has dispelled fears that In Vitro Fertilization IVF may elevate women's risk of developing breast cancer. No link between IVF and breast cancer Fears that IVF might raise women’s risk of developing breast cancer have been dispelled by a nationwide study in the Netherlands, which has found that the fertility treatment has no effect on the disease. New IVF technique could double baby chances London, Nov 11 : Researchers at the Oxford University claim to have developed a new IVF screening technique that could double the success rates for some women. Solomons official 'comfortable' with Iran financing health Health officials in the Solomon Islands say they are happy to use money from Iran to help medical students if it increases doctor numbers in the Pacific nation. Safeguard Scientifics and Oxford Bioscience Partners Co-Lead $12 Million Series a Financing for Molecular Biometrics Safeguard Scientifics, Inc. NYSE: SFE, a holding company that builds value in growth-stage technology and life sciences companies, today announced it co-led a $12 million Series A financing round with Oxford Bioscience Partners for Molecular Biometrics, Inc. The metabolomics company's lead product, ViaMetrics-ETM, is a diagnostic procedure designed to help identify the most viable embryos ... Safeguard Scientifics and Oxford Bioscience Partners Co-Lead $12 Million Series a Financing for Molecular Biometrics WAYNE, Pa.----Safeguard Scientifics, Inc. , a holding company that builds value in growth-stage technology and life sciences companies, today announced it co-led a $12 million Series A financing round with Oxford Bioscience Partners for Molecular Biometrics, Inc. Safeguard Scientifics co-leads financing of Molecular Biometrics Safeguard Scientifics Inc. said Monday it has co-led a $12 million, first-round venture-capital financing of Molecular Biometrics Inc. of Chester, N.J. Oxford Bioscience Partners of Boston was the other co-leader. SFE Financial problems halt construction on retail center Construction of the Centennial Hills Center project, a 300,000-square-foot medical and professional office and retail center on North Durango Drive and Grand Montecito Parkway, was halted on Oct. 1 due to financing problems. |


